The initial submission of this event was reported by the manufacturer under mfr report # 2916596-2018-00710.This report is being submitted as additional information.The heartmate 3 lvas was implanted during the momentum 3 clinical trial, ide# (b)(4).Fda approval for heartmate 3 lvas was received on 23 august 2017.The same device is used commercially and in the ongoing momentum 3 trial.The gtin unique device identifier for the commercial heartmate3 lvas is (b)(4).Approximate age of device - 110 days.Manufacturer's investigation conclusion: the report of low flow hazard alarms was confirmed through the analysis of the submitted system controller and lvad log files; however, the report of inflow cannula malpositioning could not confirmed through this evaluation.The submitted system controller and lvad log files showed that the system appeared to be operating as intended.A specific cause for the low flow hazard events could not be conclusively be determined through this evaluation.The heartmate 3 lvas ifu warns that care should be taken to avoid orienting the inlet towards the interventricular septum as pump function will be compromised in the presence of an inlet obstruction.This ifu provides information on all system alarms, including the low flow hazard alarm, and states that the low flow hazard alarm will be triggered when pump flow is less than 2.5 lpm.Changes in patient conditions can result in low flow.A review of the device history records, including the sterilization and packaging documentation, found no deviations from manufacturing specifications.The manufacturer is closing the file on this event.
|
The patient was implanted with a left ventricular assist device (lvad) on (b)(6) 2017.It was reported that frequent low flow alarms occurred the morning of (b)(6) 2018.The patient was medically managed; however, the low flow alarms persisted.As part of troubleshooting, the system controller was exchanged; however, the change did not resolve the alarms.The lvad speed was manually decreased; however, the alarms persisted.On (b)(6) 2018, the patient continued to be asymptomatic.The patient's left ventricle had decreased in size by 3 cm.Because of this remodeling, the inflow cannula had likely changed position enough to cause the low flow alarms.No additional interventions were pursued, and the patient was discharged.
|